<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · United Kingdom</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to United Kingdom.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/gb.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Negotiating security and resilience: planning conundrums for avian influenza control in Great Britain’s poultry systems</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1088-2976-601x-ae8dd4-7e93f829/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1088-2976-601x-ae8dd4-7e93f829/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>The research highlights critical gaps in agricultural risk management that could facilitate pathogen persistence and impact broader food security frameworks.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>One Health</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Do Digital Visual Aids Improve Skin Self-Examination Behaviours? A Systematic Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1177-10901981261479324-f115e091/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1177-10901981261479324-f115e091/</guid>
    <pubDate>Fri, 21 Aug 2026 00:00:00 GMT</pubDate>
    <description>Skin self-examination represents a secondary prevention approach for early skin cancer detection. Digital visual aids such as smartphone applications may support broader uptake and maintenance of these examination behaviors.</description>
    <category>AIDS</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Heterogeneity of use, access, and retention of insecticide-treated nets: Implications for subnational tailoring to maximise malaria control</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-7554-elife-108745-4-d5839f7f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-7554-elife-108745-4-d5839f7f/</guid>
    <pubDate>Thu, 20 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings indicate that subnational variation in net use after access may be relevant when considering malaria-control deployment strategies. The abstract describes a framework for using routinely collected data to support subnational programme tailoring.</description>
    <category>Malaria</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Effectiveness of Influenza Vaccines and Duration of Protection Against Hospitalisation During the 2024/25 Season in Northern Ireland, UK</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-irv-70303-d7a345bf/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-irv-70303-d7a345bf/</guid>
    <pubDate>Thu, 06 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings indicate that seasonal influenza vaccination provided meaningful protection against hospitalisation in 2024/25, with the largest benefit observed in children, supporting continued vaccination efforts in Northern Ireland.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Vaccine effectiveness</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Effects of attenuated influenza virus administration to young children on pneumococcal density and acquisition in UK families: a randomised controlled trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2026-101422-edc10908/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-lanmic-2026-101422-edc10908/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest LAIV-induced increases in pneumococcal density in vaccinated toddlers may transiently raise pneumococcal acquisition risk among household members, which has implications for transmission modelling at individual and population scales.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128951-d6bd0b8b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128951-d6bd0b8b/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Tracking extended safety outcomes in vaccinated populations aligns with established priorities for evaluating long-term product performance in preventive healthcare frameworks.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>The spread of sexually transmissible drug-resistant shigellosis in England: a genomic epidemiology study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00227-6-2767a2bd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-26-00227-6-2767a2bd/</guid>
    <pubDate>Wed, 01 Jul 2026 00:00:00 GMT</pubDate>
    <description>The abstract frames sexually transmissible shigellosis as a public health concern requiring interventions beyond traditional enteric-disease measures. It also highlights antimicrobial stewardship as relevant across pathogens in a syndemic setting.</description>
    <category>Shigellosis</category>
    <category>Antimicrobial resistance</category>
    <category>Genomic epidemiology</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Social contact patterns in the United Kingdom following the COVID-19 pandemic: The Reconnect cross-sectional survey</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1005038-00fad050/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1005038-00fad050/</guid>
    <pubDate>Tue, 12 May 2026 00:00:00 GMT</pubDate>
    <description>The study provides empirical post-pandemic contact data to inform mathematical models of respiratory infectious disease transmission, including the incorporation of ethnicity and socioeconomic status.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-3-2500431-37258000/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2026-31-3-2500431-37258000/</guid>
    <pubDate>Thu, 22 Jan 2026 00:00:00 GMT</pubDate>
    <description>The investigation demonstrates the value of pharyngeal swabbing for outbreak strain identification and provides initial safety evidence for off-label use of MenB-fHbp vaccine in young children who had previously received 4CMenB vaccination.</description>
    <category>Meningococcal disease</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Biosecurity Uptake and Perceived Risk of Avian Influenza Among People in Contact With Birds.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-zph-70034-c73d79cd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-zph-70034-c73d79cd/</guid>
    <pubDate>Tue, 06 Jan 2026 00:00:00 GMT</pubDate>
    <description>The observed gap between routine animal-focused protocols and human-directed precautions suggests opportunities for targeted educational outreach. Understanding these behavioral patterns can help shape communication strategies that address specific compliance obstacles within high-exposure demographics.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>One Health</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Haemophilus influenzae global epidemiology and antimicrobial susceptibility patterns including ampicillin and amoxicillin-clavulanate resistance based on β-lactamase production, 2013–2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-11438-9-fe5e80e6/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-025-11438-9-fe5e80e6/</guid>
    <pubDate>Thu, 23 Oct 2025 00:00:00 GMT</pubDate>
    <description>The findings indicate geographic variation in H. influenzae antimicrobial resistance and differences associated with beta-lactamase production. The authors state that these results support reliable susceptibility testing and resistance-containment efforts, while the abstract reports caution regarding clarithromycin in settings with high resistance.</description>
    <category>Haemophilus influenzae</category>
    <category>Antimicrobial resistance</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Systematic review and modelling of Toxoplasma gondii seroprevalence in humans, Europe, 2000 to 2021</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2025-30-34-2500069-7b3556f0/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2025-30-34-2500069-7b3556f0/</guid>
    <pubDate>Thu, 28 Aug 2025 00:00:00 GMT</pubDate>
    <description>Toxoplasma gondii infection typically causes mild or asymptomatic illness in immunocompetent individuals but can lead to severe ocular, neurological, or multi-systemic disease and even death in unborn children and immunocompromised persons. The findings establish a robust baseline for future epidemiological research and may support risk assessment studies in Europe.</description>
    <category>Toxoplasmosis</category>
    <category>Travel medicine</category>
    <category>Transmission dynamics</category>
    <category>One Health</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Avian influenza overview March-June 2025.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2903-j-efsa-2025-9520-80483e0c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2903-j-efsa-2025-9520-80483e0c/</guid>
    <pubDate>Wed, 23 Jul 2025 00:00:00 GMT</pubDate>
    <description>Human infections with currently circulating avian A(H5) clade 2.3.4.4b viruses remain rare despite widespread animal circulation; the assessed EU/EEA risk is low for the general public and low-to-moderate for those with occupational exposure to infected animals or contaminated environments.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Gastroenteritis</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Avian influenza overview December 2024-March 2025.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2903-j-efsa-2025-9352-2b62ebee/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2903-j-efsa-2025-9352-2b62ebee/</guid>
    <pubDate>Tue, 15 Apr 2025 00:00:00 GMT</pubDate>
    <description>The abstract reports that human infections remained infrequent despite circulation in animal populations. It also describes low reported risk for the general public in the EU/EEA and low-to-moderate reported risk for people occupationally or otherwise exposed to infected animals or contaminated environments.</description>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Gastroenteritis</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>An outbreak of Shiga toxin-producing Escherichia coli (STEC) O157:H7 associated with contaminated lettuce and the cascading risks from climate change, the United Kingdom, August to September 2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-36-2400161-2b6a690e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-36-2400161-2b6a690e/</guid>
    <pubDate>Thu, 05 Sep 2024 00:00:00 GMT</pubDate>
    <description>The work demonstrates integration of genomic, epidemiological and environmental data to investigate a large food-borne outbreak and to develop upstream tools that could help prevent future contamination events.</description>
    <category>Gastroenteritis</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Genomic epidemiology</category>
    <category>One Health</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Salmonella and the chicken: reflections on salmonellosis and its control in the United Kingdom</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s44364-024-00001-y-ac1c4c83/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s44364-024-00001-y-ac1c4c83/</guid>
    <pubDate>Fri, 23 Aug 2024 00:00:00 GMT</pubDate>
    <description>Mitigating poultry-associated infections remains essential for community safety, although evolving pathogen traits highlight the need for updated mitigation frameworks. Sustained evaluation of control protocols supports ongoing protection against foodborne transmission.</description>
    <category>Salmonellosis</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-24-00143-9-c153178e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-24-00143-9-c153178e/</guid>
    <pubDate>Thu, 01 Aug 2024 00:00:00 GMT</pubDate>
    <description>The paper provides context for tuberculosis vaccine development by describing a controlled human infection model intended for future evaluation of vaccine efficacy and potential correlates of protection. It does not provide evidence about population-level tuberculosis surveillance or current disease activity.</description>
    <category>Tuberculosis</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Vaccine effectiveness</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Independent clinic-based evaluation of dual POCTs for screening for HIV and syphilis in men who have sex with men in Italy, Malta, Peru, and the United Kingdom</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09019-3-5bf76d5e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09019-3-5bf76d5e/</guid>
    <pubDate>Thu, 29 Feb 2024 00:00:00 GMT</pubDate>
    <description>Dual point-of-care tests could serve as a cost-effective, patient-friendly, and provider-friendly alternative to conventional testing in clinical and field settings, particularly in resource-limited environments where validated screening tools may help reduce HIV and syphilis incidence.</description>
    <category>Syphilis</category>
    <category>AIDS</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Meta-analysis</category>
  </item>
  <item>
    <title>Transmission dynamics and effect of control measures on the 2022 outbreak of mpox among gay, bisexual, and other men who have sex with men in England: a mathematical modelling study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-23-00451-6-f4ce6dd3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-23-00451-6-f4ce6dd3/</guid>
    <pubDate>Mon, 01 Jan 2024 00:00:00 GMT</pubDate>
    <description>The findings suggest that reductions in sexual partner rates among some GBMSM drove the outbreak reversal, and that timely vaccination helped limit future resurgences, informing control strategies for future mpox outbreaks.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004245-26e774fe/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pmed-1004245-26e774fe/</guid>
    <pubDate>Wed, 07 Jun 2023 00:00:00 GMT</pubDate>
    <description>The findings inform COVID-19 vaccination policy by characterizing age- and sex-specific risks of rare cardiac adverse events after booster doses and by demonstrating risk variation by vaccine type and prior infection status. The marked difference in risk between second and third mRNA-1273 doses, which differed in mRNA content, and the lower risk in previously infected individuals provide insights relevant to dosing strategies and immunization schedules.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Surveillance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Air and surface sampling for monkeypox virus in a UK hospital: an observational study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s2666-5247-22-00257-9-c7980a75/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s2666-5247-22-00257-9-c7980a75/</guid>
    <pubDate>Thu, 01 Dec 2022 00:00:00 GMT</pubDate>
    <description>The findings demonstrate environmental contamination in isolation facilities and potential for airborne suspension of monkeypox virus during specific activities such as bedding changes. Contamination of healthcare worker PPE and doffing areas underscores the importance of infection control protocols, proper PPE use, and doffing procedures in preventing nosocomial transmission.</description>
    <category>Monkeypox</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41586-021-03398-2-abd2039f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41586-021-03398-2-abd2039f/</guid>
    <pubDate>Mon, 08 Mar 2021 00:00:00 GMT</pubDate>
    <description>The abstract frames these variants as relevant to COVID-19 interventions because some authorized and developing therapies and vaccines targeted earlier SARS-CoV-2 forms. The reported neutralization differences are relevant to treatment and vaccination considerations at a population-health level.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Rapid implementation of SARS-CoV-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-20-30562-4-5cbef4e4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-20-30562-4-5cbef4e4/</guid>
    <pubDate>Sun, 01 Nov 2020 00:00:00 GMT</pubDate>
    <description>The abstract describes rapid combined genomic and epidemiological analysis as a tool for investigating suspected health-care-associated COVID-19, detecting otherwise unrecognized transmission events, and identifying opportunities for infection-control action. The findings provide context for genomic epidemiology and outbreak investigation in hospital and community settings, without establishing effects beyond this study.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Genomic epidemiology</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Diagnostics</category>
    <category>Health policy</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0007955-be2809f8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0007955-be2809f8/</guid>
    <pubDate>Thu, 26 Dec 2019 00:00:00 GMT</pubDate>
    <description>The findings are relevant to first-line therapy of uncomplicated enteric fever in the context of emerging antimicrobial resistance, and motivate further work on azithromycin dosing regimens and combination strategies.</description>
    <category>Typhoid fever</category>
    <category>Paratyphoid fever</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Antimicrobial resistance</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-18-30355-4-b13b0392/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-18-30355-4-b13b0392/</guid>
    <pubDate>Mon, 01 Oct 2018 00:00:00 GMT</pubDate>
    <description>Optimizing diagnostic selection for high-risk demographics may enhance resource allocation by prioritizing individuals with demonstrably higher progression probabilities.</description>
    <category>Tuberculosis</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Cohort study</category>
  </item>
  <item>
    <title>Rubella infection in pregnancy and congenital rubella in United Kingdom, 2003 to 2016</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2018-23-19-17-00381-2b7b94a8/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2018-23-19-17-00381-2b7b94a8/</guid>
    <pubDate>Thu, 10 May 2018 00:00:00 GMT</pubDate>
    <description>The UK achieved WHO elimination status in 2016, with high vaccination uptake and rubella immunity in the population. Most pregnancy infections since 2003 occurred in unvaccinated women and were acquired abroad, suggesting that verification of complete immunization at every healthcare contact remains important.</description>
    <category>Rubella</category>
    <category>Congenital rubella syndrome</category>
    <category>Syphilis</category>
    <category>Measles</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-44-17-00306-d17fed69/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-44-17-00306-d17fed69/</guid>
    <pubDate>Thu, 02 Nov 2017 00:00:00 GMT</pubDate>
    <description>These results bolster the rationale for sustaining youth immunization initiatives while underscoring the continued necessity of developing robust protective strategies for elderly populations.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Vaccine effectiveness</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-42-17-00673-7817fed7/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-42-17-00673-7817fed7/</guid>
    <pubDate>Thu, 19 Oct 2017 00:00:00 GMT</pubDate>
    <description>The outbreak occurred after the United Kingdom had achieved interrupted endemic measles transmission for 36 months in 2016, illustrating the ongoing risk of imported measles cases.</description>
    <category>Measles</category>
    <category>Syphilis</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-18-30527-a68572c9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-18-30527-a68572c9/</guid>
    <pubDate>Thu, 04 May 2017 00:00:00 GMT</pubDate>
    <description>The passive enhanced safety surveillance demonstrated improved data reporting and showed suitability to health authority requirements for near real-time detection of potential increases in vaccine reactogenicity following annual influenza strain updates.</description>
    <category>Influenza</category>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Surveillance</category>
    <category>Climate and environment</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa1411627-29a1f0cd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa1411627-29a1f0cd/</guid>
    <pubDate>Thu, 28 Apr 2016 00:00:00 GMT</pubDate>
    <description>Development of an effective Ebola vaccine was identified as a priority for controlling future outbreaks following the West African epidemic that caused over 11,000 deaths.</description>
    <category>Ebola</category>
    <category>Hemorrhagic Fever</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-15-00725-4-30b7693f/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-15-00725-4-30b7693f/</guid>
    <pubDate>Fri, 01 Jan 2016 00:00:00 GMT</pubDate>
    <description>The models predict significant public health impact and high cost-effectiveness of RTS,S/AS01 vaccination across a wide range of malaria transmission settings in Africa, though implementation decisions would need to consider local burden levels, existing intervention coverage and cost-effectiveness, health priorities, financing, and delivery system capacity.</description>
    <category>Malaria</category>
    <category>Plasmodium falciparum malaria</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Transmission dynamics</category>
    <category>Health policy</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Hajj: infectious disease surveillance and control</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-14-60381-0-d4c635fa/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s0140-6736-14-60381-0-d4c635fa/</guid>
    <pubDate>Sun, 01 Jun 2014 00:00:00 GMT</pubDate>
    <description>The authors highlight that large religious gatherings pose risks for infectious disease transmission among pilgrims and to host populations, may stress the host health system, and require advance surveillance and response planning given epidemic potential.</description>
    <category>COVID-19</category>
    <category>Surveillance</category>
    <category>Travel medicine</category>
    <category>One Health</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Contact Tracing for Influenza A(H1N1)pdm09 Virus–infected Passenger on International Flight</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2001-120101-4ae7c610/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2001-120101-4ae7c610/</guid>
    <pubDate>Wed, 01 Jan 2014 00:00:00 GMT</pubDate>
    <description>The report provides evidence that contact tracing around an infected international-flight passenger can identify additional confirmed cases across passenger and community-contact groups.</description>
    <category>Influenza</category>
    <category>COVID-19</category>
    <category>Outbreak investigation</category>
    <category>Travel medicine</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Early spread of the 2009 influenza A(H1N1) pandemic in the United Kingdom – use of local syndromic data, May–August 2009</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-ese-16-03-19771-en-b3774e48/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-ese-16-03-19771-en-b3774e48/</guid>
    <pubDate>Thu, 20 Jan 2011 00:00:00 GMT</pubDate>
    <description>The abstract states that local syndromic data were used to help identify hotspots, guide limited public health resources, and monitor outbreak progression.</description>
    <category>Influenza</category>
    <category>Surveillance</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1136-bmj-39010-581354-55-48423e96/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1136-bmj-39010-581354-55-48423e96/</guid>
    <pubDate>Fri, 01 Dec 2006 00:00:00 GMT</pubDate>
    <description>The findings suggest that staff influenza vaccination programs in care homes may reduce mortality and healthcare utilization among vulnerable residents during periods of moderate influenza activity.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Health policy</category>
    <category>Randomised controlled trial</category>
  </item>
</channel>
</rss>
